Advertisement
Screener

HYPERION DEFI, INC. (HYPD) Graph

HYPD Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $357.69K; Cost of revenue (m); Research and development $58.49K; Selling, general and administrative $3.92M.
  • 2026-03-31: Revenue $244.27K; Cost of revenue (m); Research and development $286.76K; Selling, general and administrative $4.49M.
  • 2025-12-31: Revenue $496.23K*; Cost of revenue $303.24K*; Research and development $188.95K*; Selling, general and administrative $4.53M*.
  • 2025-09-30: Revenue $302.51K; Cost of revenue (m); Research and development $373.86K; Selling, general and administrative $2.59M.

Crypto Asset

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

HYPD revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Hype Digital Assets$314.12KRevenue$357.69KGross profit$357.69KOperating expenses-$30.65MOperating income$31.01MOther income, net-$29.78KResearch & development$58.49KSelling, general& administrative$3.92MNet income$30.95M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2026-06-30$357.69K(m)$58.49K$3.92M-$30.65M$30.95M
2026-03-31$244.27K(m)$286.76K$4.49M-$8.49M$8.84M
2025-12-31$496.23K*$303.24K*$188.95K*$4.53M*$39.96M*(m)
2025-09-30$302.51K(m)$373.86K$2.59M-$4.13M$6.63M
2025-06-30(m)(m)$674.58K$7.68M$8.35M-$8.69M
2025-03-31$14.72K$48.00$673.04K$2.37M$3.05M-$3.48M
2024-09-30$1.63K$132.52K$3.47M$3.73M$7.20M-$7.89M
2024-06-30$22.63K$490.36K$4.60M$3.76M$11.22M-$11.05M
2024-03-31$4.99K$203.03K$4.43M(m)$10.07M-$10.92M
2023-09-30$1.20K$13.42K$3.58M$2.93M$6.51M-$7.34M
2023-06-30(m)(m)$2.81M(m)$5.96M-$6.22M
2023-03-31(m)(m)$2.52M(m)$5.46M-$5.74M
2022-09-30$0.00$0.00$3.88M(m)$7.23M-$7.31M
2022-06-30$0.00$0.00$3.59M(m)$7.12M-$7.24M
2022-03-31$0.00$0.00$3.71M(m)$7.19M-$7.34M
2021-09-30$0.00$0.00$3.55M(m)$5.93M-$5.57M
2021-06-30$2.00M$800.00K$3.68M(m)$5.98M-$4.84M
2021-03-31$2.00M$800.00K$4.32M(m)$6.57M-$5.35M
2020-09-30(m)(m)$3.36M(m)$5.09M-$5.10M
2020-06-30$0.00$0.00$2.92M(m)$5.02M-$5.02M
2020-03-31(m)(m)$3.63M(m)$5.47M-$5.45M
2019-09-30(m)(m)$3.20M(m)$4.69M-$4.65M
2019-06-30(m)(m)$3.57M(m)$5.38M-$5.33M
2019-03-31(m)(m)$4.01M(m)$5.95M-$5.93M
2018-09-30(m)(m)$2.49M(m)$4.32M-$4.32M
2018-06-30(m)(m)$2.41M(m)$3.32M-$3.32M
2018-03-31(m)(m)$2.09M(m)$3.43M-$3.43M
2017-09-30(m)(m)$570.42K(m)$885.28K-$884.62K
2017-06-30(m)(m)$751.93K(m)$976.88K-$976.59K
2017-03-31(m)(m)$910.84K(m)$1.11M-$1.11M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2026-06-30$601.96K(m)$345.25K$8.41M-$39.14M$39.79M
2025-06-30$14.72K$48.00$1.35M$10.05M$11.40M-$12.17M
2024-06-30$27.62K$693.39K$9.03M$7.40M$21.29M-$21.98M
2023-06-30(m)(m)$5.33M(m)$11.42M-$11.96M
2022-06-30$0.00$0.00$7.30M(m)$14.31M-$14.58M
2021-06-30$4.00M$1.60M$8.01M(m)$12.55M-$10.19M
2020-06-30$0.00$0.00$6.55M(m)$10.49M-$10.47M
2019-06-30(m)(m)$7.58M(m)$11.33M-$11.27M
2018-06-30(m)(m)$4.51M(m)$6.75M-$6.75M
2017-06-30(m)(m)$1.66M(m)$2.08M-$2.08M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2025-09-30$317.23K$48.00$1.72M$12.65M$7.27M-$5.55M
2024-09-30$29.24K$825.91K$12.50M$11.13M$28.49M-$29.86M
2023-09-30$1.20K$13.42K$8.91M$9.02M$17.93M-$19.29M
2022-09-30$0.00$0.00$11.18M(m)$21.54M-$21.89M
2021-09-30$4.00M$1.60M$11.56M(m)$18.47M-$15.76M
2020-09-30(m)(m)$9.91M(m)$15.58M-$15.56M
2019-09-30(m)(m)$10.78M(m)$16.02M-$15.92M
2018-09-30(m)(m)$6.99M(m)$11.07M-$11.07M
2017-09-30(m)(m)$2.23M(m)$2.97M-$2.97M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$813.46K$303.29K$1.91M$17.18M$47.23M-$30.94K-$45.31M
2024-12-31$57.34K$3.93M$14.46M$14.33M$44.87M(m)-$49.82M
2023-12-31$3.79K$16.00K$12.98M$12.42M$25.39M(m)-$27.26M
2022-12-31(m)(m)$13.38M(m)$26.91M(m)-$28.01M
2021-12-31$14.00M$1.60M$14.85M(m)$25.42M(m)-$12.78M
2020-12-31$2.00M$800.00K$13.36M(m)$20.99M(m)-$19.77M
2019-12-31(m)(m)$14.10M(m)$21.31M$0.00-$21.16M
2018-12-31(m)(m)$11.12M(m)$17.26M$0.00-$17.25M
2017-12-31(m)(m)$3.82M(m)$5.13M$0.00-$5.13M
2016-12-31(m)(m)$2.97M(m)$3.53M$0.00-$3.53M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
XBiotech Inc. (XBIT)United States$0.066B-1.56
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76